BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28017218)

  • 1. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment and disability in 20 CIDP patients according to disease activity status.
    Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
    J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease activity in chronic inflammatory demyelinating polyneuropathy.
    Albulaihe H; Alabdali M; Alsulaiman A; Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2016 Oct; 369():204-209. PubMed ID: 27653889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative value and determinants of suitability of outcome measures in treated chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Ghasemi M
    Muscle Nerve; 2020 Feb; 61(2):182-186. PubMed ID: 31650551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
    Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    Neurology; 2014 Dec; 83(23):2124-32. PubMed ID: 25378677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    J Neurol Sci; 2010 Oct; 297(1-2):11-4. PubMed ID: 20673919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
    van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
    J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
    Lawley A; Seri S; Rajabally YA
    Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Vibration Perception Thresholds in CIDP Patients Indicate More Severe Neuropathy and Lower Treatment Response Rates.
    Abraham A; Albulaihe H; Alabdali M; Qrimli M; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    PLoS One; 2015; 10(11):e0139689. PubMed ID: 26545096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Afzal S; Ghasemi M
    Muscle Nerve; 2021 Jul; 64(1):37-42. PubMed ID: 33835480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
    Vanhoutte EK; Draak TH; Gorson KC; van Nes SI; Hoeijmakers JG; Van der Pol WL; Notermans NC; Lewis RA; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):289-95. PubMed ID: 26114893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
    J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postural tremor and chronic inflammatory demyelinating polyneuropathy.
    Cao Y; Menon P; Ching-Fen Chang F; Mahant N; Geevasinga N; Fung VS; Vucic S
    Muscle Nerve; 2017 Mar; 55(3):338-343. PubMed ID: 27421831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
    J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment.
    Pegat A; Boisseau W; Maisonobe T; Debs R; Lenglet T; Psimaras D; Azoulay-Cayla A; Fournier E; Viala K
    J Peripher Nerv Syst; 2020 Jun; 25(2):162-170. PubMed ID: 32364302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal loss at time of diagnosis as biomarker for long-term disability in chronic inflammatory demyelinating polyneuropathy.
    Al-Zuhairy A; Jakobsen J; Moldovan M; Krarup C
    Muscle Nerve; 2022 Dec; 66(6):715-722. PubMed ID: 36217677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.